Zhejiang Jolly Pharmaceutical Co Ltd (300181)

Currency in CNY
18.91
+0.04(+0.21%)
Closed·
300181 Scorecard
Full Analysis
Management has been aggressively buying back shares
300181 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.8319.13
52 wk Range
11.5319.98
Key Statistics
Bid/Ask
18.90 / 18.91
Prev. Close
18.87
Open
18.87
Day's Range
18.83-19.13
52 wk Range
11.53-19.98
Volume
12.23M
Average Volume (3m)
18.66M
1-Year Change
27.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300181 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.00
Upside
+16.34%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Zhejiang Jolly Pharmaceutical Co Ltd Company Profile

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, it offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, the company provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. The company also invests and participates in the medical services of Deqing No.3 People’s Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, the People’s Republic of China.

Employees
2125
Market
China

Compare 300181 to Peers and Sector

Metrics to compare
300181
Peers
Sector
Relationship
P/E Ratio
24.0x31.2x−0.5x
PEG Ratio
0.86−0.170.00
Price/Book
4.2x3.2x2.6x
Price / LTM Sales
4.8x4.8x3.3x
Upside (Analyst Target)
16.5%15.0%43.5%
Fair Value Upside
Unlock4.8%6.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.00
(+16.34% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.79%
Dividend Yield
3.17%
Industry Median 1.51%
Annualised payout
0.60
Paid annually
5-Years Growth
+97.44%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.26 / --
Revenue / Forecast
824.43M / --
EPS Revisions
Last 90 days

300181 Income Statement

FAQ

What Stock Exchange Does Zhejiang Jolly Pharma Trade On?

Zhejiang Jolly Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang Jolly Pharma?

The stock symbol for Zhejiang Jolly Pharma is "300181."

What Is the Zhejiang Jolly Pharma Market Cap?

As of today, Zhejiang Jolly Pharma market cap is 13.09B.

What Is Zhejiang Jolly Pharma's Earnings Per Share (TTM)?

The Zhejiang Jolly Pharma EPS (TTM) is 0.79.

When Is the Next Zhejiang Jolly Pharma Earnings Date?

Zhejiang Jolly Pharma will release its next earnings report on 27 Oct 2025.

From a Technical Analysis Perspective, Is 300181 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Zhejiang Jolly Pharma Stock Split?

Zhejiang Jolly Pharma has split 3 times.

How Many Employees Does Zhejiang Jolly Pharma Have?

Zhejiang Jolly Pharma has 2125 employees.

What is the current trading status of Zhejiang Jolly Pharma (300181)?

As of 09 Aug 2025, Zhejiang Jolly Pharma (300181) is trading at a price of 18.91, with a previous close of 18.87. The stock has fluctuated within a day range of 18.83 to 19.13, while its 52-week range spans from 11.53 to 19.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.